Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/25/14 → 9/25/16 |
Funding
- Clovis Oncology, Inc. (Prot #CO-3810-025)
Prot #CO-3810-025: A Phase 2, Randomized, Open-Label, Multicenter, Safety and Efficacy Study of Oral Lucitanib in Patients with FGF Aberrant Metastatic Breast Cancer
- Gradishar, William J (PD/PI)
Project: Research project